Almost 40,000 seniors will be forced to change Medicare Advantage plans after yet another insurer decides to exit markets over cost concerns. Centene Corp announced it would be ending its Medicare ...

Centene is suing the federal government over its 2025 Medicare Advantage star ratings, the latest in a string of lawsuits from health insurers looking to protect their scores — and the valuable ...

Centene’s business is still impacted by Medicaid redeterminations, a process that began in early 2023, the company said during the Wells Fargo Healthcare Conference. The insurer’s stock price dropped ...

Centene reported a $1.1 billion fourth quarter loss as the health insurer struggles with rising healthcare costs in the ...

On Tuesday, Centene touted healthy membership growth in Affordable Care Act plans, while arguing that Medicaid and Medicare — businesses that proved rocky last year — will stabilize in 2025. Already ...

Centene Corp (NYSE: CNC) shares are trading sharply lower Tuesday morning after federal regulators outlined 2027 Medicare Advantage payment changes that amounted to effectively flat funding for ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Health insurer Centene reported a $6.6 billion third-quarter loss as the ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

Centene swung to a loss in its latest quarter and described the results as "disappointing," the latest indication of the rough patch it's going through. The managed-care specialist's troubles began in ...

Health insurance companies have grappled with higher-than-expected medical costs all year, rattling investors and prompting strategical and tactical shifts, especially in Medicare and Medicaid. In ...

Shares of health insurer Centene fell on Friday on concerns about medical costs in the company’s Medicaid plans, amid what has been an exceedingly rocky earnings season for the managed-care firms.